editorial
-
Health
Kneecap resurfacing should become standard in knee replacement, 20-year trial suggests
The longest randomised controlled trial in knee orthopaedics found that resurfacing the kneecap during total knee replacement delivers greater long-term…
Read More » -
Pharma
Biogen to acquire RayThera in deal worth up to $1 billion
The acquisition adds multiple immunology assets to Biogen’s pipeline, including a lead anti-inflammatory candidate expected to enter Phase 1 development…
Read More » -
Pharma
FDA approves Utebzi, first oral carbapenem antibiotic for complicated urinary tract infections in adults
New oral treatment could help eligible patients receive care outside hospital settings instead of relying on intravenous antibiotics The US…
Read More » -
Technology
AI analysis of eye scans could transform disease screening
AI-powered eye scans may help detect heart and brain disease risk years earlier. Researchers at The University of Manchester have…
Read More » -
Policy
UK launches national lymph node research network
The UK-wide initiative brings together 10 specialist research centres to study human lymph nodes, with a focus on improving vaccine…
Read More » -
Pharma
FDA approves first hyaluronic acid injectable to reduce horizontal neck lines
The U.S. Food and Drug Administration (FDA) has approved SKINVIVE by Juvéderm for reducing horizontal neck lines and improving neck…
Read More » -
Policy
India Tightens Control on Cough Syrups as Government Closes a Decades-Old Regulatory Loophole
For decades, cough syrups could be sold in many of India’s smallest villages with fewer regulatory checks than in towns…
Read More » -
Technology
ICMR-NIE, IISc launch ADARV platform to strengthen outbreak intelligence
The free-to-use platform combines epidemiology, data science and artificial intelligence to help researchers and field teams analyse outbreak data faster,…
Read More » -
Health
Urine drug test may improve adherence to blood pressure treatment, UK trial finds
The largest UK trial of a urine-based medication adherence test found that discussing test results with patients improved adherence to…
Read More » -
Pharma
KEYTRUDA-WELIREG combination wins FDA approval for high-risk kidney cancer after surgery
Approval is based on Phase III LITESPARK-022 trial results showing a 28% reduction in the risk of disease recurrence, metastasis…
Read More »








